Learn about the ongoing clinical trials for canine lymphoma conducted by the Werling Comparative Oncology Research Center (WCORC).

NEW experimental treatment for dogs with aggressive lymphomas (LSA; B or T cell) with genetically modified Vesicular Stomatitis Virus (VSV).

The purpose of this trial is to determine whether dogs with DLBCL can be safely treated with CHOP chemotherapy in which all 4 drugs are given on the same day.

Diagnosis of lymphoma must be confirmed by cytology or biopsy for the dog to be eligible for this study. Dogs will be randomized to receive the investigational ...

Welcome to a resource for information on current research trials in veterinary oncology. Pet owners often ask us if we are aware of any CLINICAL TRIALS.

Clinical trials are funded in part by the Cornell Canine Health Center and the Cornell Feline Health Center. Consider a gift to help more animals through ...

Study Description: This study will proceed according to a two-center, open-label, nonrandomized, clinical trial in dogs with treatment naïve DLBCL.

The purpose of this study is to evaluate different doses of bendamustine in dogs with lymphoma to evaluate its safety and effectiveness. cancer active lymphoma ...

A new combination of drugs (ibrutinib + mivibresib) will be tested in a phase II clinical study in untreated dogs that have been newly diagnosed with B-cell ...

2 нояб. 2023 г. · The study will evaluate the safety and preliminary efficacy of administering VCAA chemotherapy followed by ECI to treat canine lymphoma. We are ...